opioid substitution therapy

6.

NGOs call on Global Fund Board to sustain catalytic investments in harm reduction in next allocation cycle

26 Feb 2019
Briefing highlights impact of harm reduction investments in MICs

In January, Harm Reduction International and the International HIV/AIDS Alliance (now Frontline AIDS) released a joint briefing urging the Global Fund Board to sustain investments in harm reduction interventions as the Fund considers its allocation methodology and catalytic funding priorities for the 2020-2022 period.

4.

Tanzania's TB/HIV funding request to the Global Fund yields three grants

6 Mar 2018
Funding request identifies vulnerable groups for TB

Mainland Tanzania submitted a funding request for its HIV and TB components that resulted in the Global Fund Board approving three grants, including a TB/HIV grant to a civil society principal recipient (PR) –– AMREF Health Africa. The Ministry of Finance and Planning (MOFP) was awarded an HIV grant and a TB grant.

Subscribe to opioid substitution therapy